Skip to main content
Book ChapterOPEN ACCESS

Antiviral Resistance in Influenza Viruses: Clinical and Epidemiological Aspects

  • van der Vries E
  • Ison M
Springer International Publishing, (2017), 1165-1183
DOI: 10.1007/978-3-319-47266-9_23
N/ACitations
Citations of this article
13Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

There are three classes of antiviral drugs approved for the treatment of influenza: the M2 ion channel inhibitors (amantadine, rimantadine), neuraminidase (NA) inhibitors (laninamivir, oseltamivir, peramivir, zanamivir), and the protease inhibitor (favipiravir); some...

Cite

CITATION STYLE

APA

van der Vries, E., & Ison, M. G. (2017). Antiviral Resistance in Influenza Viruses: Clinical and Epidemiological Aspects. In Antimicrobial Drug Resistance (pp. 1165–1183). Springer International Publishing. https://doi.org/10.1007/978-3-319-47266-9_23

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free